Unter der Annahme, dass „antibody“ benötigt wird und „therapies“ benötigt wird, wurden folgende Ergebnisse gefunden:

  • Development of lead molecules for antibody therapies

    André Frenzel, YUMAB GmbH, Braunschweig,Germany Antibody phage display has been used for the discovery of therapeutic antibodies since decades. Although several alternative technologies have been developed in the meantime such as single B-cell cloning...

    https://www.elrig.de/index.php/elrig-foren/elrig-forum-2020/forum2020-abstracts/304-frenz-abs20

  • ELISA - Oldie but Goldie? A notorious and still viable method for AAV gene therapy

    Lisa Mutz, Progen, Heidelberg The Enzyme-Linked Immunosorbent Assay (ELISA) has a long history in the field of immunoassays. Yet, in the ever-evolving landscape of AAV gene therapy, its continued relevance is worth checking. This presentation aims to...

    https://www.elrig.de/index.php/elrig-foren/elrig-forum-2024/forum2024-abstracts/412-abstract-lisa-mutz-progen-heidelberg-24

  • MOSAIC: Providing true flexibility for parallel batch ATMP production

    Holger Saal, KyooBe, Leinfelden-Echterdingen A new area in medicine–cell therapies–show promising patient outcomes but still lack commercial success and market access. Why? Most current approaches face challenges in bridging the gap between early...

    https://www.elrig.de/index.php/elrig-foren/elrig-forum-2024/forum2024-abstracts/413-abstract-holger-saal-kyoobe-leinfelden-echterdingen-24

Ergebnisse 1 - 3 von 3

pfeil zurueck pfeil top